Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCentro di Riferimento Oncologico - Aviano

About this trial

The advances in early detection coupled with improvements in treatments have led to an ever-increasing number of breast cancer survivors. New methods to improve outcomes, including strategies aimed at improving the quality of life and reducing the risk of other diseases, may represent valid additions to the currently available treatment options. Interventions targeting diet, weight and physical activity can reduce the risk of cancer occurrence, prevent cancer recurrence, improve survival and the quality of life.

This is an observational, prospective study aimed at evaluating the effects of physical activity on the quality of life of patients with early stage hormone receptor positive breast cancer receiving adjuvant hormonal therapy and adhering to a physical activity program lasting for a total of 12 weeks organized by ANDOS onlus (Associazione Italiana Donne Operate al Seno).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with early stage (I-IIIa) hormone receptor-positive breast cancer receiving adjuvant endocrine therapy

Female patients ≥18 years of age

Written informed consent must be obtained before any study-related assessment is performed

Participation to the Medicina and Sport physical activity program organized by Andos Pordenone

Disqualifiers

Patients with early hormone receptor negative breast cancer

Patients with early hormone receptor positive breast cancer receiving chemotherapy

Patients with advanced/metastatic breast cancer.

Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias).

Trial population

Early stage hormone receptor positive breast cancer patients participating to the Medicina and Sport

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Change in Quality of Life as measured by the EORTC QLQ-C30 questionnaire.

Mean differences on the questionnaire will be evaluated. The EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire) is a 30-item validated tool used to assess the physical, psychological, and social functions of cancer patients. Higher scores on functional scales and the global health status represent a higher/better level of functioning, while higher scores on symptom scales represent a higher level of symptomatology.

Time frame
Up to 6 months after the end of the physical activity program

Secondary outcomes

1

Change from Baseline in Pain Intensity (Brief Pain Inventory - Short Form)

Pain intensity will be assessed using the Brief Pain Inventory (BPI) Severity score, rated on an 11-point Likert scale from 0 (no pain) to 10 (pain as bad as you can imagine). A higher score indicates greater pain intensity.

Time frame
Up to 6 months after the end of the physical activity program
2

Change from Baseline in Physical Activity Levels

Subjective physical fitness and activity will be evaluated using the IPAQ (International Physical Activity Questionnaire). This questionnaire assesses walking, moderate-intensity, and vigorous-intensity activities. Results are reported as Metabolic Equivalent of Task (MET)-minutes per week. Higher MET-minutes indicate higher physical activity levels.

Time frame
Up to 6 months after the end of the physical activity program
3

Change from Baseline in Dietary Habits and Nutritional Intake

Evaluated through food diaries provided during nutritional visits. The diaries assess caloric intake and macronutrient distribution (carbohydrates, proteins, fats).

Time frame
Up to 6 months after the end of the physical activity program
4

Change from Baseline in Blood Test Results

Difference in mean of laboratory parameters as collected during routine nutritional visits to assess the metabolic impact of the program.

Time frame
Up to 6 months after the end of the physical activity program

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.